Biotech, medtech and healthtech companies in Hong Kong can join HKSTP's Incu-Bio Programme, a four-year in-person incubation on rolling intake for which applicants set out a four-year milestone plan. Support runs to HK$6 million per company: a HK$4 million financial subsidy plus a HK$2 million upfront grant towards regulatory activities such as clinical trials. Because it is provided as subsidy and grant, no equity terms are stated.
This programme has notes explaining its undisclosed figures, available in the full dataset.
Every figure above is taken from these pages, published by the programme or its parent organisation.
Last verified 2026-09-05.